XCath

CompanyUnited States

XCath develops one asset, in human trials (Iris System in acute ischemic stroke). Mostly device; based in the United States.

1
Asset
Furthest stage
Human trials
0
Trials
0
Signals

Pipeline

1
  • Iris System

    Remote robotic-assisted mechanical thrombectomy system.

    Human trials, Device, acute ischemic stroke

Full company profiles: pipeline, trials, funding and people.

See Pro

Intelligence